The Psychiatric Molecular Genetics Group works to advance knowledge of the molecular genetics of psychiatric disorders through a strong multidisciplinary research environment. The group has multiple active research projects in collaboration with NORMENT2050, a major collaborative effort studying clinical characteristics, neurocognitive functioning, genetics and brain biology of psychotic disorders and with the newly formed Centre for Precision Psychiatry (OUH/UiO).

Aims

Our research aims are to:

• perform molecular genetic analyses to increase the knowledge and expertise in psychiatric genetics and genomics
• identify the molecular networks underlying psychiatric disorders
• continually develop an organization to support psychiatric genomics and stem cell studies with design and planning and experiments.
• continuously foster new ideas 

• Human induced pluripotent stem cell (hiPSC) technologies in psychiatric molecular genetics (Figure 1)
• Neuro-immune interactions (Figure 2)
• Identifying the polygenic basis of the human brain and neurodevelopmental disorders 
• Understanding the function of ANK3 in psychotic disorders
• Identifying mechanisms of rare genetic variants in population level brain imaging genetics for clinical subtyping in neurodevelopmental disorders
• Prediction of longitudinal outcome and brain phenotype by polygenic risk scores
• Genetics of neuropsychopharmaceutics
• Cooperation and biobanking with large-scale studies including the national cohorts and further collaboration with other large-scale studies for validation and QC steps

Contact information:
Group Leader Srdjan Djurovic, Department of Medical Genetics, Tel: +47 22 11 98 90
E-mail: srdjan.djurovic@medisin.uio.no